title: Assisting judges in screening medical practice guidelines for health care litigation.
abstract: In a far-reaching decision about scientific evidence in federal cases handed down at the very end of the 1992-1993 term, the U.S. Supreme Court implicated medical practice guidelines in indirect, profound, yet highly uncertain ways. In Daubert v Merrell Dow Pharmaceuticals, Inc the Court ruled that judges must actively screen novel scientific evidence to assure both its relevance and its reliability.
authors.affiliation: Center for Health Policy Research, George Washington University, Washington, DC 20052.
authors.forename: F M
authors.initials: FM
authors.lastname: Zweig
authors.forename: H A
authors.initials: HA
authors.lastname: Witte
mesh_terms: D005104:Expert Testimony / Q000331:legislation & jurisprudence; D006801:Humans; D007400:Interprofessional Relations; D008318:Malpractice / Q000331:legislation & jurisprudence*; D017410:Practice Guidelines as Topic; D011785:Quality Assurance, Health Care / Q000331:legislation & jurisprudence; D009626:Terminology as Topic